Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order
The executive order announced by US president Donald Trump to slash prescription drug prices is unlikely to have a material near-term impact on Indian pharmaceutical companies, though it may influence…
Dabur To Withdraw ‘Anti-bacterial’ Claims from Toothpaste Labels
Dabur India Ltd has told the Bombay High Court that it will withdraw terms like “anti-inflammatory,” “anti-bacterial,” and “analgesic” from the labels of its two toothpaste products, Dabur Meswak Toothpaste…
